Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

AstraZeneca PLC

+ Add to Watchlist

ZEGA:GR

59.730 EUR 1.248 2.05%

As of 10:45:19 ET on 06/02/2015.

Snapshot for AstraZeneca PLC (ZEGA)

Open: 61.053 Day's Range: 59.528 - 61.740 Volume: 0
Previous Close: 60.978 52wk Range: 50.525 - 68.290 1-Yr Rtn: +16.17%

Stock Chart for ZEGA

No chart data available.
  • ZEGA:GR 59.730
  • 1D
  • 1M
  • 1Y
60.978
Interactive ZEGA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ZEGA

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 15.7314
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) 4.2430
Est. PEG Ratio -
Market Cap (M EUR) 75,475.29
Shares Outstanding (M) 1,263.61
30 Day Average Volume 58
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 5.60%
Cash Dividend (USD) 1.8800
Dividend Ex-Date 02/18/2015
5 Year Dividend Growth 7.30%
Next Earnings Announcement 07/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ZEGA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ZEGA

AstraZeneca PLC is a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia, and Infection.

Pascal SoriotCEO/Executive DirectorMarc DunoyerCFO/Executive Director
Shobie RamakrishnanChief Technology OfficerDavid SmoleyChief Information Officer
More Company Profile & Key Executives for ZEGA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil